Compare SUVEN LIFE with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES J.B.CHEMICALS SUVEN LIFESCIENCES/
J.B.CHEMICALS
 
P/E (TTM) x 19.9 15.4 129.2% View Chart
P/BV x 4.0 2.1 189.5% View Chart
Dividend Yield % 0.5 0.6 94.6%  

Financials

 SUVEN LIFESCIENCES   J.B.CHEMICALS
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
J.B.CHEMICALS
Mar-18
SUVEN LIFESCIENCES/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs338363 93.0%   
Low Rs169255 66.4%   
Sales per share (Unadj.) Rs52.1169.1 30.8%  
Earnings per share (Unadj.) Rs6.816.6 41.2%  
Cash flow per share (Unadj.) Rs8.623.4 36.6%  
Dividends per share (Unadj.) Rs1.502.00 75.0%  
Dividend yield (eoy) %0.60.6 91.4%  
Book value per share (Unadj.) Rs65.3172.5 37.8%  
Shares outstanding (eoy) m127.2883.57 152.3%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.91.8 266.2%   
Avg P/E ratio x37.118.6 199.4%  
P/CF ratio (eoy) x29.613.2 224.2%  
Price / Book Value ratio x3.91.8 216.8%  
Dividend payout %22.012.0 182.3%   
Avg Mkt Cap Rs m32,27225,827 125.0%   
No. of employees `0001.13.8 28.7%   
Total wages/salary Rs m6612,511 26.3%   
Avg. sales/employee Rs Th6,132.23,747.4 163.6%   
Avg. wages/employee Rs Th611.1665.7 91.8%   
Avg. net profit/employee Rs Th803.5367.8 218.5%   
INCOME DATA
Net Sales Rs m6,63514,135 46.9%  
Other income Rs m242366 66.2%   
Total revenues Rs m6,87714,501 47.4%   
Gross profit Rs m1,6042,178 73.6%  
Depreciation Rs m221570 38.9%   
Interest Rs m3835 108.0%   
Profit before tax Rs m1,5871,940 81.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718552 130.0%   
Profit after tax Rs m8691,387 62.7%  
Gross profit margin %24.215.4 156.9%  
Effective tax rate %45.228.5 158.8%   
Net profit margin %13.19.8 133.5%  
BALANCE SHEET DATA
Current assets Rs m6,23210,470 59.5%   
Current liabilities Rs m1,4902,749 54.2%   
Net working cap to sales %71.554.6 130.8%  
Current ratio x4.23.8 109.8%  
Inventory Days Days8655 156.6%  
Debtors Days Days8378 106.4%  
Net fixed assets Rs m4,0435,811 69.6%   
Share capital Rs m127167 76.2%   
"Free" reserves Rs m8,18314,248 57.4%   
Net worth Rs m8,31014,416 57.6%   
Long term debt Rs m180-   
Total assets Rs m10,38917,649 58.9%  
Interest coverage x43.156.6 76.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.8 79.7%   
Return on assets %8.78.1 108.4%  
Return on equity %10.59.6 108.7%  
Return on capital %19.513.7 142.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,6226,164 91.2%   
Fx outflow Rs m1,7991,334 134.8%   
Net fx Rs m3,8224,829 79.1%   
CASH FLOW
From Operations Rs m3561,231 28.9%  
From Investments Rs m-279-208 133.9%  
From Financial Activity Rs m-225-595 37.8%  
Net Cashflow Rs m-148427 -34.7%  

Share Holding

Indian Promoters % 63.4 55.4 114.4%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 0.0 3.4 -  
FIIs % 0.0 3.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 37.0 98.6%  
Shareholders   37,287 30,437 122.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   DR. REDDYS LAB  IPCA LABS  ASTRAZENECA PHARMA  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  

Compare SUVEN LIFESCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 334 Points Lower; IT and Telecom Stocks Witness Huge Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day deep in the red. At the closing bell, the BSE Sensex stood lower by 334 points (down 0.9%).

Related Views on News

SUVEN LIFESCIENCES Surges by 6%; BSE HEALTHCARE Index Up 0.5% (Market Updates)

Oct 22, 2019 | Updated on Oct 22, 2019

SUVEN LIFESCIENCES share price has surged by 6% and its current market price is Rs 284. The BSE HEALTHCARE is up by 0.5%. The top gainers in the BSE HEALTHCARE Index is SUVEN LIFESCIENCES (up 5.7%). The top losers are AJANTA PHARMA and CADILA HEALTHCARE .

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Oct 22, 2019 03:37 PM

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS